EX-10.19
from S-1
3 pages
Reference Is Made to That Certain Securities Purchase Agreement (The “Agreement”), Dated as of May 19, 2014, by and Between Axxess Pharma, Inc., a Nevada Corporation (The “Company”), and Seaside 88, LP, a Florida Limited Partnership (Such Investor, Including Its Successors and Assigns, “Seaside”), Pursuant to Which the Company Agreed to Issue and Sell, and Seaside Agreed to Purchase, Up to 5,000,000 Shares of the Common Stock, Par Value $0.0001 Per Share, of the Company Upon the Terms and Subject to the Conditions Set Forth Therein. Capitalized Terms Used Herein Without Definition Shall Have the Meanings Assigned to Such Terms in the Agreement
12/34/56